Breaking News Instant updates and real-time market news.

ICPT

Intercept

$65.37

-0.69 (-1.04%)

04:55
08/15/19
08/15
04:55
08/15/19
04:55

Intercept management to meet with Oppenheimer

Meeting to be held in New York, NY on August 15 hosted by Oppenheimer.

  • 15

    Aug

ICPT Intercept
$65.37

-0.69 (-1.04%)

07/10/19
CANT
07/10/19
NO CHANGE
Target $191
CANT
Overweight
Cantor says Intercept management confident in Ocaliva's blockbuster potential
Cantor Fitzgerald analyst Alethia Young said she spoke to Intercept's CEO and CFO amid questions from investors about the stock weakness today, which she believes is due to competitor comments around the commercial potential for Ocaliva in PBC and NASH. Management expressed no change in their view for the commercial opportunity for either indication, continue to believe that Ocaliva will be a key therapy for advanced fibrosis patients with NASH and "remain confident in OCA's blockbuster potential," according to Young. She maintains a $191 price target and Overweight rating on Intercept shares.
07/10/19
FBCO
07/10/19
NO CHANGE
FBCO
Outperform
Intercept weakness appears 'unfounded,' says Credit Suisse
Credit Suisse analyst Michael Morabito says he spoke with Intercept regarding the weakness in the shares, which he has attributed to negative competitor comments. Management reiterated its commercial outlook has not changed and maintains that while the company does not anticipate a bolus of patients at launch like what was seen for HCV, it does see a long period of steady growth in NASH and is confident in the long-term commercial outlook for obeticholic acid, he adds. Morabito believes the weakness will be short-lived and that Intercept shares are likely to return to their prior levels. He has an Outperform rating on the shares. In afternoon trading, the stock has dropped almost 7% to $74.52.
08/06/19
OPCO
08/06/19
NO CHANGE
Target $160
OPCO
Outperform
Intercept price target lowered to $160 from $170 at Oppenheimer
Oppenheimer analyst Jay Olson lowered his price target for Intercept to $160 from $170 on valuation. Nonetheless, the analyst continues to view the selloff in the shares post REGENERATE Phase 3 as an "overreaction." Olson remains confident that Intercept has the first approvable registrational study in NASH for a drug that is already approved for PBC. He reiterates an Outperform rating on the shares.
08/08/19
OPCO
08/08/19
NO CHANGE
Target $150
OPCO
Outperform
Intercept price target lowered to $150 from $160 at Oppenheimer
Oppenheimer analyst Jay Olson lowered his price target for Intercept (ICPT) to $150 from $160, while reiterating an Outperform rating on the shares following quarterly results. The analyst recognizes the PBC business faces challenges including the potential for price erosion assuming OCA becomes available for NASH at a higher dose and lower price and multiple competitive entries including CymaBay's (CBAY) seladelpar, which is also being studied for NASH. Olson also believes recent competitor studies in NASH increase the scarcity value of Intercept's registrational asset, and thinks MRI-PDFF results for seladelpar have no impact on Intercept's plans to study a combination of OCA plus bezafibrate in NASH. Additionally, he considers the Q3 regulatory submission for OCA in NASH as a positive catalyst if granted a priority review.

TODAY'S FREE FLY STORIES

LZB

La-Z-Boy

$30.55

-1.325 (-4.16%)

16:18
08/20/19
08/20
16:18
08/20/19
16:18
Hot Stocks
Breaking Hot Stocks news story on La-Z-Boy »

La-Z-Boy reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

LZB

La-Z-Boy

$30.55

-1.325 (-4.16%)

16:18
08/20/19
08/20
16:18
08/20/19
16:18
Hot Stocks
La-Z-Boy reports Q1 SSS for company-owned Retail segment up 3.5% »

In Q1: Written same-store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

NRZ

New Residential

$14.14

-0.115 (-0.81%)

16:17
08/20/19
08/20
16:17
08/20/19
16:17
Hot Stocks
New Residential announces $200M share repurchase program »

New Residential…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
08/20/19
08/20
16:17
08/20/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEDG

SolarEdge

$84.71

0.57 (0.68%)

16:16
08/20/19
08/20
16:16
08/20/19
16:16
Hot Stocks
SolarEdge appoints Uri Bechor as COO »

SolarEdge Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LZB

La-Z-Boy

$30.55

-1.325 (-4.16%)

16:16
08/20/19
08/20
16:16
08/20/19
16:16
Earnings
La-Z-Boy reports Q1 adjusted EPS 42c, consensus 34c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
08/20/19
08/20
16:16
08/20/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLXS

Plexus

$57.04

-0.48 (-0.83%)

16:15
08/20/19
08/20
16:15
08/20/19
16:15
Hot Stocks
Plexus announces $50M share repurchase program »

Plexus announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$48.56

-0.38 (-0.78%)

16:15
08/20/19
08/20
16:15
08/20/19
16:15
Initiation
Total initiated  »

Total initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:15
08/20/19
08/20
16:15
08/20/19
16:15
General news
Breaking General news story  »

San Francisco Federal…

XOM

Exxon Mobil

$69.03

-0.42 (-0.60%)

16:14
08/20/19
08/20
16:14
08/20/19
16:14
Initiation
Exxon Mobil initiated  »

Exxon Mobil initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LL

Lumber Liquidators

$8.42

0.36 (4.47%)

16:13
08/20/19
08/20
16:13
08/20/19
16:13
Hot Stocks
Lumber Liquidators founder Sullivan discloses 5.96% stake »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$115.99

-1.31 (-1.12%)

16:12
08/20/19
08/20
16:12
08/20/19
16:12
Initiation
Chevron initiated  »

Chevron initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$55.71

-0.37 (-0.66%)

16:11
08/20/19
08/20
16:11
08/20/19
16:11
Initiation
Royal Dutch Shell initiated  »

Royal Dutch Shell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$36.45

-0.41 (-1.11%)

16:11
08/20/19
08/20
16:11
08/20/19
16:11
Initiation
BP initiated  »

BP initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

URBN

Urban Outfitters

$20.98

0.12 (0.58%)

16:09
08/20/19
08/20
16:09
08/20/19
16:09
Hot Stocks
Breaking Hot Stocks news story on Urban Outfitters »

Urban Outfitters down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

SCSC

Scansource

$31.55

-0.24 (-0.75%)

16:09
08/20/19
08/20
16:09
08/20/19
16:09
Earnings
Scansource sees Q1 non-GAAP EPS 70c-75c, consensus 35c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 19

    Sep

URBN

Urban Outfitters

$20.97

0.11 (0.53%)

16:09
08/20/19
08/20
16:09
08/20/19
16:09
Hot Stocks
Urban Outfitters says total inventory increased by $64.4M as of July 31 »

As of July 31, total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

URBN

Urban Outfitters

$20.96

0.1 (0.48%)

16:08
08/20/19
08/20
16:08
08/20/19
16:08
Hot Stocks
Urban Outfitters reports Q2 comparable retail segment net sales down 3% »

Q2 comparable retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

URBN

Urban Outfitters

$20.92

0.06 (0.29%)

16:07
08/20/19
08/20
16:07
08/20/19
16:07
Earnings
Urban Outfitters reports Q2 EPS 61c, consensus 58c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

SCSC

Scansource

$31.85

0.06 (0.19%)

16:06
08/20/19
08/20
16:06
08/20/19
16:06
Earnings
Scansource reports Q4 non-GAAP EPS 71c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 19

    Sep

REI

Ring Energy

$1.66

-0.07 (-4.06%)

16:06
08/20/19
08/20
16:06
08/20/19
16:06
Earnings
Ring Energy releases mid-Q3 operations update »

Ring Energy released a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYBX

Synlogic

$3.45

-1.37 (-28.42%)

16:06
08/20/19
08/20
16:06
08/20/19
16:06
Downgrade
Synlogic rating change  »

Synlogic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$58.36

0.08 (0.14%)

16:03
08/20/19
08/20
16:03
08/20/19
16:03
Earnings
Cree sees Q1 adjusted EPS (7c)-(3c), consensus 15c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

MOGO

Mogo Finance

$2.60

(0.00%)

16:03
08/20/19
08/20
16:03
08/20/19
16:03
Hot Stocks
Mogo Finance surpasses 900,000 member milestone »

Mogo announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.